Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Townsend

Showing results (231-240 of 250) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Pathogens (Basel, Switzerland)|March 29, 2023
Design and Optimization of a <i>Monkeypox virus</i> Specific Serological AssayTaha Y Taha, Michael B Townsend, Jan Pohl, et al.
Vaccine|May 18, 2024
Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.)Isabel Griffin, Isha Berry, Terese Navarra, et al.
MMWR. Morbidity and Mortality Weekly Report|October 25, 2019
Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019Erin R Whitehouse, Agam K Rao, Yon C Yu, et al.
Vaccine|November 7, 2022
Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of CongoLalita Priyamvada, William C Carson, Eddy Ortega, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2023
Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022Yasmin P Ogale, Nicolle Baird, Michael B Townsend, et al.
Emerging Infectious Diseases|October 13, 2023
Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June-September 2022Faisal S Minhaj, Vijay Singh, Stephanie E Cohen, et al.
Plos Neglected Tropical Diseases|April 20, 2023
Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the CongoPhillip R Pittman, James W Martin, Placide Mbala Kingebeni, et al.
The Lancet. Infectious Diseases|March 12, 2026
Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort studyFaisal S Minhaj, Anna Mandra, Béatrice U Nguete, et al.
The Lancet. Infectious Diseases|March 12, 2026
Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort studyLalita Priyamvada, Faisal S Minhaj, Toutou Likafi, et al.
Pageof 25

Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Pathogens (Basel, Switzerland)|March 29, 2023
Design and Optimization of a <i>Monkeypox virus</i> Specific Serological AssayTaha Y Taha, Michael B Townsend, Jan Pohl, et al.
Vaccine|May 18, 2024
Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.)Isabel Griffin, Isha Berry, Terese Navarra, et al.
MMWR. Morbidity and Mortality Weekly Report|October 25, 2019
Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019Erin R Whitehouse, Agam K Rao, Yon C Yu, et al.
Vaccine|November 7, 2022
Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of CongoLalita Priyamvada, William C Carson, Eddy Ortega, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2023
Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022Yasmin P Ogale, Nicolle Baird, Michael B Townsend, et al.
Emerging Infectious Diseases|October 13, 2023
Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June-September 2022Faisal S Minhaj, Vijay Singh, Stephanie E Cohen, et al.
Plos Neglected Tropical Diseases|April 20, 2023
Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the CongoPhillip R Pittman, James W Martin, Placide Mbala Kingebeni, et al.
The Lancet. Infectious Diseases|March 12, 2026
Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort studyFaisal S Minhaj, Anna Mandra, Béatrice U Nguete, et al.
The Lancet. Infectious Diseases|March 12, 2026
Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort studyLalita Priyamvada, Faisal S Minhaj, Toutou Likafi, et al.
Pageof 25